References
- Polyakov A, Cohen S, Baum M, et al. Patterns of antenatal corticosteroid prescribing 1998–2004. Aust N Z J Obstet Gynaecol 2007;47:42–5
- Mahony R, McKeating A, Murphy T, et al. Appropriate antenatal corticosteroid use in women at risk for preterm birth before 34 weeks of gestation. BJOG 2010;117:963–7
- Dutch Society for Obstetrics and Gynaecology (NVOG). Threatened preterm labour. Guideline version 2.0. Utrecht, The Netherlands: NVOG; 2004
- Vis JY, Wilms FF, Kuin RA, et al. Time to delivery after the first course of antenatal corticosteroids: a cohort study. Am J Perinatol 2011;28:683–8
- Peaceman AM, Bajaj K, Kumar P, Grobman WA. The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes. Am J Obstet Gynaecol 2005;193:1165–9
- Waters TP, Mercer B. Impact of timing of antenatal corticosteroid exposure on neonatal outcomes. J Matern Fetal Neonatal Med 2009;22:311–4
- Koenen SV, Dunn EA, Kingdom JC, et al. Overexposure to antenatal corticosteroids: a global concern. J Obstet Gynaecol Can 2007;29:879
- Crowther CA, Doyle LW, Haslam RR, et al. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N Engl J Med 2007;357:1179–89
- Wapner RJ, Sorokin Y, Mele L, et al. Long term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med 2007;357:1190–8
- Peltoniemi OM, Kari MA, Lano A, et al. Two-year follow-up of a randomised trial with repeated antenatal betamethasone. Arch Dis Child Fetal Neonatal Ed 2009;94:F402–6
- Guinn DA, Atkinson MW, Sullivan L, et al. Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery. JAMA 2001;286:1581–7
- Murphy KE, Hannah ME, Willan AR, et al. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet 2008;372:2143–51
- Tijsseling D, Wijnberger LDE, Derks JB, et al. Effects of antenatal glucocorticoid therapy on hippocampal histology of preterm infants. PLoS ONE 2012;7:e33369
- ten Berg MJ, Huisman A, van den Bemt PM, et al. Linking laboratory and medication data: new opportunities for pharmacoepidemiological research. Clin Chem Lab Med 2007;45:13–9
- Sanchez-Ramos L, Delke I, Zamora J, Kaunitz AM. Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients: a meta-analysis. Obstet Gynaecol 2009;114:631–40
- Sotiriadis A, Papatheodorou S, Kavvadias A, Makrydimas G. Transvaginal cervical length measurement for prediction of preterm birth in women with threatened preterm labor: a meta-analysis. Ulstrasound Obstet Gynaecol 2010;35:54–64
- Dutch Society for Obstetrics and Gynaecology (NVOG). Hypertensive disorders in pregnancy. Guideline version 1.0. Utrecht, The Netherlands: NVOG; 2007
- Dutch Society for Obstetrics and Gynaecology (NVOG). Intrauterine growth restriction. Guideline version 2.1. Utrecht, The Netherlands: NVOG; 2008
- Wijnberger LDE, de Kleine M, Voorbij HAM, et al. Prediction of fetal lung immaturity using gestational age, patient characteristics and fetal lung maturity tests: a probabilistic approach. Arch Gynaecol Obstet 2010;281:15–21